American Thrombosis and Hemostasis Network
11
3
4
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
9.1%
1 terminated/withdrawn out of 11 trials
85.7%
-0.8% vs industry average
9%
1 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
ATHNdataset Registry
Role: lead
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Role: lead
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Role: lead
ATHN 9: Severe VWD Natural History Study
Role: lead
ATHN 7: Hemophilia Natural History Study
Role: lead
ATHN 11: Liver Transplantation Outcomes Study
Role: lead
Characterizing the Impact and Treatment of Reproductive Tract Bleeding on Women and Post-menarchal Girls With Bleeding Disorders
Role: collaborator
ATHN 8: Previously Untreated Patients (PUPs) Matter Study
Role: lead
Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry
Role: collaborator
ATHN 2: Factor Switching Study
Role: lead
Ceprotin Treatment Registry
Role: collaborator
All 11 trials loaded